Position in RMTI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6
New position
Shares Held
1
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 36 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026COMPASS FINANCIAL MANAGEMENT LLC holds $2,555,806 across 7 Drug Manufacturers - Specialty & Generic names. RMTI ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
88,233 | $1,401,140 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,254 | $1,092,765 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
1,546 | $53,599 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,000 | $7,920 | |
| 5 | ZTS |
Zoetis Inc.
|
4 | $287 | |
| 6 | TLRY |
Tilray Brands, Inc.
|
20 | $89 | |
| 7 | RMTI |
Rockwell Medical, Inc.
This page
|
1 | $6 |
All Filings in RMTI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6 | 12 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||